The widening role of computer simulation in drug, research is surveyed. Examples covered include the simulation of biological membranes and the prediction of the structures of interleukin receptors.
RobinsonA.J., RichardsW.G., ThomasP.J., and HannM.M. (1994). Head group and chain behaviour in biological membranes: a molecular dynamics computer simulation.Biophysical Journal67, 2345–2354.
2.
KempD.J., NorbeckD.W., CadscoviL., WangX.C., KohlbrennerW.E., WideburgN.G., PaulD.A., KniggeM.F., VasamondaS., Craig-KennardA., SolvidarA., RosenbrookW.Jnr., ClementJ.J., PlatnerJ.J., and EricksonJ.W. (1990). Structure-based, C2 symmetric inhibitors of HIV proteases.Journal of Medicinal Chemistry33, 2687–2791.
3.
LamP.Y.S., JadhavP.K., EyermannC.J., HodgeC.N., RuY., BachelerL.T., MeekJ.L., OttoM.J., RaynerM.M., WongY.N., ChangC.H., WeberP.C., JacksonD.A., SharpT.R., and EricksonviitanenS. (1994). Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.Science263, 380–384.
4.
KimE.E., BakerC.T., DwyerM.D., MurckoM.A., RaoB.G., TungR.D., and NaviaM.A. (1995). Crystal structure of HIV-1 protease in a complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme.Journal of the American Chemical Society117, 1181–1182.
5.
AppeltK., BacquetR.J., BartlettC.A., BoothC.L.J., FreerS.T., FuhryM.A.M., GehringM.R., HerrmannS.M., HowlandE.E., JansenC.A., JonesT.R., KanC-C., KathardelcarV., LewisK.K., MarzoniG.P., MatthewsD.A., MohrC., MoomawE.W., MorseC.A., OatleyS., OgdenR.C., ReddyM.F., ReichS.H., SchoettlinW.S., SmithN.W., VarneyM.D., VillafrancaJ.E., WardR.W., WebberS., WebberS.E., WelshK.M., and WhiteJ. (1991). Design of eynzyme inhibitors using iterative protein crystallographic analysis.Journal of Medicinal Chemistry34, 1925–1931.
6.
BamboroughP., HedgecockC.J.R., and RichardsW.G. (1994). The interleukin-2 and interleukin-4 receptors studied by molecular modelling.Structure2, 839–851.
7.
WellsJ.A., & de VosA.M. (1993). Structure and function of human growth hormone: implications for the hematopoietins.Annual Review of Biophysics and Biomolecular Structure22, 329–351.
8.
Van GunsterenW.F., KingP.M., and MarkA.E. (1994). Fundamentals of drug design from a biophysical viewpoint.Quarterly Review of Biophysics27, 435–481.
9.
ZupanJ., and GasteigerJ. (1993). Neural Networks for Chemists, 305 pp. Weinheim, Germany: VCH.
10.
GoodA.C., SoS-S., & RichardsW.G. (1993). Structure-activity relationships from molecular similarity matrices.Journal of Medicinal Chemistry36, 433–438.
